Last reviewed · How we verify
NCT05342571
A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer
NA trial testing Behavioral, Psychological or Informational Intervention in Advanced Lung Carcinoma in 30 participants. Completed in 1 September 2022.
30 July 2022
Quick facts
| Lead sponsor | Ohio State University Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 1 June 2021 |
| Primary completion | 30 July 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Behavioral, Psychological or Informational Intervention
- Biospecimen Collection — full drug profile →
- Electronic Health Record Review
- Informational Intervention
- Survey Administration
Conditions studied
- Advanced Lung Carcinoma — all drugs for Advanced Lung Carcinoma →
- Metastatic Lung Carcinoma — all drugs for Metastatic Lung Carcinoma →
- Stage IV Lung Cancer AJCC v8 — all drugs for Stage IV Lung Cancer AJCC v8 →
- Stage IVA Lung Cancer AJCC v8 — all drugs for Stage IVA Lung Cancer AJCC v8 →
Sponsor
Ohio State University Comprehensive Cancer Center
Who can join
18 and older, any sex, with Advanced Lung Carcinoma or Metastatic Lung Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This phase IIb trial studies the effect of a biobehavioral/cognitive (ABC) treatment on stress, depression, and anxiety in patients with stage IV lung cancer. Advanced lung cancer and stress or depression are associated with increased inflammation and decreased immunity. ABC is a combination of biobehavioral intervention, which studies the interaction between behavioral and biological processes, and cognitive therapy for the treatment for anxiety and depressive disorders. Giving ABC during lung cancer treatment may reduce stress, depression, and anxiety, and improve patients' quality of life and health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05342571
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Behavioral, Psychological or Informational Intervention
Trials testing the same drug.
- NCT05595135 — Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4 · NA · withdrawn
- NCT04754412 — Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Br · NA · active not recruiting
- NCT05036408 — Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal N · NA · completed
- NCT04062552 — Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Can · NA · active not recruiting
- NCT03808818 — Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices · NA · completed
Other recruiting trials for Advanced Lung Carcinoma
Currently open trials in the same condition.
- NCT05705492 — Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancre · Phase 2 · recruiting
- NCT05969860 — At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · Phase 2 · recruiting
- NCT04819997 — A Nurse-Led Intervention for Fear of Progression in Advanced Cancer · NA · active not recruiting
- NCT03707938 — Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer · Phase 1 · active not recruiting
Other Ohio State University Comprehensive Cancer Center trials
Trials by the same sponsor.
- NCT06816979 — Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell · NA · not yet recruiting
- NCT07529483 — Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts · Phase 2 · not yet recruiting
- NCT07455513 — A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer · NA · not yet recruiting
- NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting
- NCT07503925 — THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05342571 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center
- Last refreshed: 23 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05342571.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing